Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Immunovant, Inc. (IMVT)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Dec-31-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Net income    -166.6-156.7-137.7-128.1-111.2-107.4
Depreciation and amortization   [+]  0.20.20.10.10.10.1
Stock-based compensation    41.938.131.727.618.718.8
Change in working capital   [+]  6.444.534.937.419.820.8
Other operating activities    -53.8-53.3-45.9-44.7-18.1-15.6
Cash from operations    -171.9-127.3-116.9-107.8-90.7-83.3
   
Capital expenditures    -0.3-0.3-0.2-0.2-0.2-0.2
Cash from investing    -0.3-0.3-0.2-0.2-0.2-0.2
   
Repurchase of common stock, net     -200.00.0200.0  
Option exercises    0.0     
Other cash from financing    400.2400.2201.02.2190.5384.0
Cash from financing    200.2200.2201.0201.4189.7383.1
   
Free cash flow    -172.2-127.6-117.1-108.0-90.9-83.5
        Per share (diluted)    ($1.53)($1.18)($1.14)($1.10)($0.99)($0.98)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy